Evidence map›Paper›PMID 20511492›Full record

ArticleJournal of lipid research2010

STARTing to understand MLN64 function in cholesterol transport.

Attilio Rigotti, David E Cohen, Silvana Zanlungo

Abstract readComment
In one paragraph

Article in Journal of lipid research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The unsolved mystery of apoA-I recycling in adipocyte.Lipids in health and disease · 2016
    Review
  6. Article
  7. Article
  8. Article
  9. Genetics of cholesterol efflux.Current atherosclerosis reports · 2012
    Review
  10. Regulation of cholesterol homeostasis.Cellular and molecular life sciences : CMLS · 2012
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Attilio RigottiDepartamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica, Santiago, Chile.
David E Cohen
Silvana Zanlungo

Funding

Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLDR01DK056626 · NIDDK · YESHIVA UNIVERSITY · PI COHEN, DAVID E. · 2000 to 2024
$10.3M
Regulation of Hepatic Lipid and Glucose Metabolism by Phosphatidylcholine TransfeR01DK048873 · NIDDK · YESHIVA UNIVERSITY · PI DAVID E. COHEN · 2003 to 2026
$5.8M
Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2R37DK048873 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI COHEN, DAVID E. · 2012 to 2021
$5.5M
MOLECULAR PHYSIOLOGY OF BILIARY LIPID SECRETIONR29DK048873 · NIDDK · YESHIVA UNIVERSITY · PI COHEN, DAVID E · 1996 to 2000
$147k
NIDDK NIH HHS DK48873NIDDK NIH HHS DK56626NIDDK NIH HHS R01 DK048873NIDDK NIH HHS R01 DK056626NIDDK NIH HHS R29 DK048873NIDDK NIH HHS R37 DK048873
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiological TransportCholesterolHumansMembrane ProteinsProtein Structure, TertiaryCholesterolMembrane Proteins

Identifiers

PMID20511492
PMCPMC2903795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.